No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
8-K: Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates
10-Q: Q3 2024 Earnings Report
8-K: Windtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business Updates
10-Q: Q2 2024 Earnings Report
10-Q: Q1 2024 Earnings Report
8-K: Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates